Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Aptose Biosciences Inc. T.LOR

Sector: Healthcare | Sub-Sector: Biotechnology
Primary Symbol: T.APS

Aptose Biosciences Inc is engaged in discovering and developing therapeutics and molecular diagnostics that target the underlying mechanisms of cancer. Its product APTO-253 is a novel small molecule that demonstrates anti-tumor activity in cancer cells.
Price: N/A Volume: 0
Change: N/A % Change: N/A
Day High/Low: N/A/N/A 52 Week High/Low: N/A/N/A
Last Traded: N/A Transaction Volume:
Open: Previous Close:
Bid: Ask:
Bid Size: 0 Ask Size: 0
Market Cap: N/A Shares Out: 139.3m
PE Ratio: N/A Dividend Yield: N/A

Opinion

Pinetree Capital's three favourite 'high potential tech plays'

Tommy Humphreys   February 3, 2014
0 stars

Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Mystery Movers: Biomed shares surging, triple digit rises all over, executives baffled

When you're standing on a launchpad and a rocket is taking off, the best place to be is on the rocket.

Chris Parry   November 19, 2013
0 stars

Mystery Movers: Spectral Diagnostics jumps 22% as Canadian biotech goes viral

You're still looking for rocks in the ground? Get with the program: Biotech is booming.

Chris Parry   November 5, 2013
0 stars

Latest Bullboard Posts

  • RE:RE:RE:Oppenheimer

    0 stars

    "debunk the Lorus stuff"??? What? You think people are going to stand up and talk about what happened with Lorus 5-10 years ago? The...

    2 stars


  • RE:RE:Oppenheimer

    0 stars

    Present at the Openheimer.Too funny,unfortunately there may be some smart people there that will debunk all this Lorus stuff that went on...

    4 stars


  • Won't be long before LOR is a U.S. Co.

    0 stars

    Happened to notice that todays N/R was posted at 5.00 AM PST and that the lease on the old Lorus location expires, I believe, in March of...

    2.5 stars


  • RE:Oppenheimer

    0 stars

    Yes with a $17 initial target price. They present at the Oppenheimer 25th Annual Healthcare conference tomorrow at 1:00pm.

    2 stars


  • Oppenheimer

    0 stars

    Research analysts at Oppenheimer assumed coverage on shares of Aptose Biosciences (NASDAQ:APTO) in a report released on Monday. The firm...

    2.5 stars